Skip to main content
Tech.euFundingExplorerBeta

Vaxdyn

innovative vaccine platform that helps prevent infections and reduce the global threat of antimicrobial resistance

Vaxdyn has raised €26M across 2 funding rounds from 4 investors, most recently a round in Sep 2026. Based in Seville, Spain; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€26M
€25,500,000
Funding rounds
2
Investors
4
distinct backers
Active since
2024-09
latest 2026-09

Funding by year

EUR raised per year · 2026 YTD
Vaxdyn — funding by year — interactive chart.
Data table
Vaxdyn — funding by year
2024€15M
2026€11M

Signals

High confidence
Raise-next likelihood11
base rate 30% for Other
  • ▼ Raised very recently
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-09-10Other€11MArcano Partners,Biovance Capital,EIC FundView deal →
2024-09-04Other€15MEIC AcceleratorView deal →

Similar companies

same sector or country

Global coverage: FundingData